2022 annual financial data
Puma Biotechnology 2022 Operating margin
Direct answer
Operating margin was 10.4%.
Operating income was 23,720,000 USD and net income was 2,000 USD.
Operating cash flow was -15,827,000 USD.
Get free Puma Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 228,031,000 USD
- Operating income
- 23,720,000 USD
- Net income
- 2,000 USD
- Operating cash flow
- -15,827,000 USD